Clinical Trial Update: A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II trial of Calcitriol and Naproxen in recurrent prostate cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• Naproxen (Naproxen)

Snippet

Sponsor: Stanford University | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 2 | Status: TERMINATED